Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy
D Cohen, JPAM Bogers, D van Dijk… - The Journal of clinical …, 2012 - psychiatrist.com
Objective: Clozapine is the preferred option for treatment-resistant schizophrenia. However,
since 1975, clozapine has been known to cause agranulocytosis. In the clozapine screening …
since 1975, clozapine has been known to cause agranulocytosis. In the clozapine screening …
Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy.
D Cohen, JP Bogers, D van Dijk, B Bakker… - The Journal of Clinical …, 2012 - europepmc.org
Objective Clozapine is the preferred option for treatment-resistant schizophrenia. However,
since 1975, clozapine has been known to cause agranulocytosis. In the clozapine screening …
since 1975, clozapine has been known to cause agranulocytosis. In the clozapine screening …
[引用][C] Beyond White Blood Cell Monitoring: Screening in the Initial Phase of Clozapine Therapy
D COHEN, J BOGERS, M PA, DV DIJK… - The Journal of …, 2012 - pascal-francis.inist.fr
Beyond White Blood Cell Monitoring: Screening in the Initial Phase of Clozapine Therapy
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy
D Cohen, JPAM Bogers, D van Dijk… - The Journal of …, 2012 - pubmed.ncbi.nlm.nih.gov
Objective Clozapine is the preferred option for treatment-resistant schizophrenia. However,
since 1975, clozapine has been known to cause agranulocytosis. In the clozapine screening …
since 1975, clozapine has been known to cause agranulocytosis. In the clozapine screening …
Beyond White Blood Cell Monitoring: Screening in the Initial Phase of Clozapine Therapy
D Cohen, JPAM Bogers, MD Daniel van Dijk… - J Clin …, 2012 - psychiatrist.com
Objective: Clozapine is the preferred option for treatment-resistant schizophrenia. However,
since 1975, clozapine has been known to cause agranulocytosis. In the clozapine screening …
since 1975, clozapine has been known to cause agranulocytosis. In the clozapine screening …
[引用][C] Beyond White Blood Cell Monitoring
D Cohen, JPAM Bogers, D van Dijk, B Bakker… - The Journal of Clinical …, 2012 - cir.nii.ac.jp
Beyond White Blood Cell Monitoring | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁
[サイニィ] 詳細へ移動 検索フォ恁啶匾動 論文・デ恁郡颏丹す 大学図書館の本をさがす 日本の博士 …
[サイニィ] 詳細へ移動 検索フォ恁啶匾動 論文・デ恁郡颏丹す 大学図書館の本をさがす 日本の博士 …
Beyond White Blood Cell Monitoring: Screening in the Initial Phase of Clozapine Therapy
D Cohen, JPAM Bogers, D van Dijk… - Journal of Clinical …, 2012 - research.rug.nl
Objective: Clozapine is the preferred option for treatment-resistant schizophrenia. However,
since 1975, clozapine has been known to cause agranulocytosis. In the clozapine screening …
since 1975, clozapine has been known to cause agranulocytosis. In the clozapine screening …